Bibliographic Details
Title: |
Indolent B-cell non-Hodgkin lymphomas in children: high association with inborn errors of immunity. |
Authors: |
Kurucu, Nilgün, Kutluk, Tezer, Sağlam, Arzu, Cagdas, Deniz, Haliloğlu, Mithat, Salancı, Bilge Volkan, Aydın, Burça, Yalçın, Bilgehan, Varan, Ali, Üner, Ayşegül |
Source: |
Leukemia & Lymphoma; Dec2024, Vol. 65 Issue 12, p1875-1882, 8p |
Subject Terms: |
MUCOSA-associated lymphoid tissue lymphoma, CHILDHOOD cancer, NON-Hodgkin's lymphoma, FOLLICULAR lymphoma, LYMPHOMAS |
Abstract: |
Indolent lymphomas are rare in children and mostly consist of pediatric type follicular (PTFL) and pediatric marginal zone lymphomas (PMZL) and extranodal marginal zone lymphoma (ENMZL). Twenty children with indolent lymphoma (10 PTFL, 6 PMZL, 3 ENMZL, 1 mixed type) among 307 Non-Hodgkin Lymphoma (NHL) were retrospectively evaluated. The mean age of the entire group was 10.4 ± 4.4 and was significantly lower in PTFL than in PMZL. Seven patients (35%) had an associated inborn error of immunity (IEI) which was higher than that seen in aggressive lymphomas (5.9%) (p < 0.0001). Seventeen patients (85%) had stage I/II disease. Two patients received no treatment after surgery. Eleven patients were treated only with 3-6 courses of rituximab. Four patients received 3-6 courses of R-CHOP protocol. The prognosis was excellent Five years overall and event-free survivals were 100% and 85%, respectively. [ABSTRACT FROM AUTHOR] |
|
Copyright of Leukemia & Lymphoma is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
Database: |
Complementary Index |
Full text is not displayed to guests. |
Login for full access.
|